Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
miR-631
- Development stage
- Preclinical
- Lead developer
- PURMX Therapeutics
- Modality
- MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
miR-631 is a microRNA-based therapeutic candidate being developed by PURMX Therapeutics for the treatment of various solid tumors. Originating from research at Hiroshima University, the drug is a small RNA nucleic acid designed to modulate the activity of miR-631 as part of the company's "Aging switch" platform. This approach focuses on using specific miRNAs to regulate gene expression patterns associated with cancer progression. The therapeutic is currently in the basic research stage, with potential applications in a wide range of cancers, including lung, pancreatic, and colorectal malignancies.
- Other names
- miR-631 miRNA therapeuticmiR631 miRNA therapeuticmiR 631 miRNA therapeutic
02
Targets
E2F2 (E2F transcription factor 2)PTPRE (Receptor-type tyrosine-protein phosphatase epsilon)
Beyond the preview
Go deeper on miR-631.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on miR-631.